Bosentan treatment of digital ulcers related to systemic sclerosis: results from the RAPIDS-2 randomised, double-blind, placebo-controlled trial
Marco Matucci‐Cerinic(Vita-Salute San Raffaele University), James R. Seibold(University of Michigan), Mittie K. Doyle(Tulane University), Vivien Hsu(Rutgers, The State University of New Jersey), CP Denton(The Royal Free Hospital), Patrick Carpentier(Université Grenoble Alpes), Bernhard Hellmich(University Children's Hospital Tübingen), Nadera Sweiss(University of Illinois Chicago), C. M. Black(Merck & Co., Inc., Rahway, NJ, USA (United States)), Peter A. Merkel(University of Pennsylvania), D.E. Furst(University of California, Los Angeles), A. Morganti(Actelion (Switzerland)), Thomas A. Medsger(University of Pittsburgh), Barri J. Fessler(Cleveland Clinic), Janet Pope(St Joseph's Health Care), J H Korn(Boston University), Maureen D. Mayes(The University of Texas Health Science Center)
Cited by 503
Related Papers
2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides
|Arthritis & Rheumatism|2012|6.6k
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
|Annals of the Rheumatic Diseases|2020|2.8k
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update
|Annals of the Rheumatic Diseases|2022|1.9k
2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides
|UNC Libraries|2020|1.3k